Category: Bioinformatics |
| + Scansite: A World-Wide-Web Interfaced Bioinformatic Computer Program to Predict Sites of Protein-Protein Interaction and Protein Phosphorylation (BIDMC 245) |
Category: Diagnostics/Biomarkers |
| + Diagnosis and Treatment of Cell-Cell Junction Related Disorders (BIDMC 1028) |
| + Diagnostic and Therapeutic Target for Statin-induced Muscle Damage (BIDMC 1270) |
| + Diagnostic test for epithelial cancers, including endometrial, based on serum levels of adiponectin and associated therapeutic compounds (BIDMC 715)
|
| + Modified PMSA Ligands and Related Uses (BIDMC 407) |
| + Molecular Markers for Women's Infertility and Therapeutic Targets (BIDMC 1040) |
| + Non-invasive Assessment of Therapeutic Toxicity and Efficacy from Physiologic Measurements (BIDMC 895) |
| + Novel ECG-based Method for Identification of Ischemia-Induced Precordial T-Wave Inversions (BIDMC 817) |
| + Rapid Anthrax Diagnosis & Treatment (BIDMC 1136) |
| + Rapid Diagnostic to Distinguish between Sepsis and Injury-Induced SIRS (BIDMC 1363) |
Category: Drug Delivery |
| + Targeting Endothelium for Tissue-Specific Delivery of Therapeutic Agents (BIDMC 181)
|
| + Wortmannin Conjugates and Uses Thereof (BIDMC 952) |
Category: Drug Discovery Tools |
| + A New Optics-based Quantitative Method for Assessment of RBC Flickering (BIDMC 1049) |
| + Anti-Angiogenic Properties of Type 1 Repeats of Thrombospondin 1 (TSP repeat) (BIDMC 402)
|
| + Calcium-Independent Negative Regulation of CD81 Receptor Signaling (BIDMC 324) |
| + Dual Anti-Proliferative and Pro-Apoptotic Functions of A20 in Smooth Muscle Cells (BIDMC 301) |
| + NERF and ELF-1 as Novel Transcriptional Mediators of Angiogenesis and Therapeutic Drug Targets (BIDMC 541)
|
| + Role of Ghrelin in Intestinal Bowel Disorders (BIDMC 741) |
| + The use of RTEF-1, a novel VEGF stimulator, for the treatment of abnormal angiogenesis (BIDMC 799) |
| + Use of Platelet Derived Growth Factor Receptor Inhibitors for The Treatment of Vascular Access Dysfunction (BIDMC 696) |
Category: Foods and Plant Sciences |
| + Dietary Formulation Comprising Arachidonic Acid and Methods of Use (BIDMC 351)
|
Category: Medical Devices |
| + Catheter-guided Endotrachael Intubation Using a Flexible Videoendoscope (BIDMC 1098) |
| + Endoscopic Suture Needle Remover and Storage Device (BIDMC 1067) |
| + Method and Apparatus for Detecting Microscopic Objects (BIDMC 635) |
| + Micro-Scale Resonant Devices & Methods of Use (BIDMC 860) |
| + Non-Invasive Apparatus & Method for Assessing Neuromuscular Disease (BIDMC 777) |
| + Novel Percutaneous Valve Repair System (BIDMC 1058) |
| + Pericardial Reinforcement Device (BIDMC 950) |
| + Polarized Light Scattering Spectroscopy Endoscopic Scanning Instrument (BIDMC 1246) |
| + Syringe with Internal Pressure Gauge (BIDMC 1076) |
| + Tissue Transplant and Regeneration Device and Method to Treat Ischemic Heart Disease (BIDMC 960)
|
| + Transatrial Catheter Access for Pericardial Space (BIDMC 191) |
| + Transcranial Magnetic Stimulation (TMS) Apparatus & Methods (BIDMC 1065) |
Category: Medical Imaging |
| + Arterial Spin Labeling Using Time Varying Gradients for Enhanced Fluid-Flow Imaging (BIDMC 634) |
| + Charge-Balanced Imaging Agents (BIDMC 1205) |
| + Charge-Coupled Devices for Wavelength-Selective Imaging (BIDMC 707) |
| + Continuous Arterial Spin Labeling with Pulsed Radiofrequency Sequences for Enhanced Fluid-Flow Imaging (BIDMC 958) |
| + Hyperpolarized MRI Contrast Agents Reveal Bloodflow (BIDMC 1034) |
| + Imaging of Cancer via Intraoperative Coded Aperture Radioscintigraphy (BIDMC 717) |
| + Imaging System Development and Training of Technologists and Surgeons with their Operation (BIDMC 880) |
| + Intraoperative Imaging Methods (BIDMC 1027) |
| + Invisible Light Fluorescent Platelets for Intraoperative Detection of Vascular Thrombosis (BIDMC 1043) |
| + Medical Imaging System and Contrast Agents (BIDMC 681) |
| + Near-Infrared and Infrared Quantum Dots for Intravascular Imaging (BIDMC 759) |
| + Near-Infrared Fluorescent Albumin for Intraoperative Imaging (BIDMC 815) |
| + Near-Infrared Fluorescent Fibrinogen for Optical Imaging of Thrombosis and Hemorrhage (BIDMC 872) |
| + Noise Reduction System and Methods for Magnetic Resonance Imaging (BIDMC 1107) |
| + Novel Histology Methods (BIDMC 1051) |
| + PEGylated Fluorophores for In Vivo Imaging (BIDMC 1033) |
| + Radio Frequency Impedance Mapping for Medical Imaging (BIDMC 701) |
| + Reactive Tetrahedral Scaffolds for Tumor Targeting (BIDMC 793) |
| + Simultaneous Acquisition of Spatial Harmonics (SMASH): Ultra-Fast Imaging with Radiofrequency Coil Arrays (BIDMC 354) |
| + Solid-Phase Conversion of Tc-99m Pertechnetate to a Reactive N-Hydroxysuccinimide Ester (BIDMC 947) |
Category: Research Reagents |
| + Human monoclonal antibody against desmoglein 3 (clone PVMAB786) (BIDMC 1341) |
| + Human monoclonal antibody against HIV gp120 (clones F223, F424, F425A1, F425B4A1g8, F425B4e8) (BIDMC 1303) |
| + Monoclonal antibodies against human Fc epsilon receptor (clones 15/1, 3G6, 4H7.1) (BIDMC 1294) |
| + Monoclonal antibodies against human SAP (BIDMC 1324) |
| + Monoclonal antibodies against human SPDEF (BIDMC 1340) |
| + Monoclonal antibodies against mouse CD39 (clones 3C1 and 5F2) (BIDMC 1211) |
| + Monoclonal antibodies against mouse LY108 (clones 13G3-19D and 330-AJ) (BIDMC 1314) |
| + Monoclonal antibodies against mouse SAP (BIDMC 1323) |
| + Monoclonal antibodies against mouse SLAM (BIDMC 1296) |
| + Monoclonal antibodies against rat CD81 (BIDMC 1321) |
| + Polyclonal Antibodies against TRMP4 (BIDMC 1319) |
| + Rat basophilic leukemia cells expressing human FcεRI α-, ß- and γ-chains (known as RBL-SX38 cell line) (BIDMC 1293) |
| + Transfection Reagents for Cell Cultures and Tissures (BIDMC 1132) |
Category: Research Tools |
| + An Inducible/Reversible Transgenic Mouse Model of BCR/ABL Leukemia (BIDMC 133) |
| + beta-1,2,3 adrenergic receptor triple knockout mouse (BIDMC 1311) |
| + Melanocortin 4 receptor knockout mice (loxTB-MC4R mice) (BIDMC 1316) |
| + Transcriptionally-disrupted orexin receptor mice (loxTD-OX1R and loxTD-OX2R mice) (BIDMC 1338) |
| + Transgenic Animals Deficient in Endogenous beta-3 Adrenergic Receptor and Uses Thereof (BIDMC 335) |
| + Transgenic mice expressing human FcEpsilon Receptor (BIDMC 1318) |
| + Transgenic mice expressing the cre gene in POMC neurons (BIDMC 1315) |
| + Transgenic Non-Human UCP2 Knockout Mouse (BIDMC 328) |
Category: Software/Algorithms |
| + Non-Invasive Coronary Vein MR Imaging (BIDMC 1072) |
| + Non-Invasive Pulmonary MR Imaging (BIDMC 1274) |
| + Pulse Sequence for Positive Contrast in MRI CEST (BIDMC 1180) |
| + Technique for Rapid Noise Reduction in Parallel MR Images (BIDMC 1107) |
| + Ultrasound Localization & Image Fusion for the Treatment of Prostate Cancer (BIDMC 1224) |
Category: Therapeutics - Drugs |
| + Alpha-1-Antitrypsin as a Treatment for Diabetes (BIDMC 1063) |
| + Anti-Cancer Peptides (BIDMC 1253) |
| + Anti-CD63 Antibodies for Allergies or Inflammation (BIDMC 743) |
| + Anti-platelet Compounds that Inhibit Thrombosis by Selective G-protein Modulation (BIDMC 622)
|
| + Chimeric IL-10 Proteins to Treat Diabetes or Prevent Septic Shock (BIDMC 239) |
| + Compounds that Increase Insulin Secretion (BIDMC 745) |
| + Conformation-Specific Antibodies (BIDMC 1061) |
| + Drug Targets for Diarrhea and Intestinal Inflammation (BIDMC 854) |
| + Genes and Proteins for the Treatement of Pre-eclampsia (BIDMC 859) |
| + Inhibition of graft failure, using MARCKS siRNAs (BIDMC 899) |
| + Methods and Compositions for Regulating Protein-Protein Interactions (BIDMC 106) |
| + Methods and Compositions for the Treatment and Diagnosis of Statin-Induced Myopathy (BIDMC 1015) |
| + Novel Angiogenic Therapies Using PR39 and Syndecan Proteins (BIDMC 101)
|
| + Novel Gene Therapy Target for Cancer and Proliferative Retinopathies (BIDMC 1264) |
| + Novel Nutritional Food Products for Improved Digestion and Intestinal Absorption (BIDMC 1089) |
| + Novel Prostate Cancer Immunotherapies (BIDMC 1187)
|
| + Parathyroid Hormone Antagonists (BIDMC 560) |
| + Peptide Analogues of Parathyroid Hormone and PTH-related Protein (BIDMC 694) |
| + Pin 1 as a Marker for Abnormal Cell Growth (BIDMC 270) |
| + Theraupeutic Use of Embryonic Cerebrospinal Fluid (eCSF) (BIDMC 1131) |
| + Treatment & Prevention of Latent Herpesvirus Reactivation (BIDMC 953) |
| + Use of DHA to treat Cystic Fibrosis (BIDMC 41) |
| + VEGF/PlGF Signaling as a Target for Sepsis (BIDMC 917) |
Category: Therapeutics - Methods |
| + A Method for Inhibiting Complement Activation during Organ Transplantation (BIDMC 623) |
| + A Nonsurgical Method for Repairing Damaged Cartilage In the Knee (BIDMC 838) |
| + Angiogenesis Inhibition Via Thrombin Protease Activity (BIDMC 684) |
| + Cell-based Therapy for Auto- and Alloimmune Responses (BIDMC 1045) |
| + Diagnostic & Therapeutic for Vascular Leak (BIDMC 962) |
| + HSPA12B as a Target for Endothelial Diesease Treatment & Diagnosis (BIDMC 955) |
| + Identification of Small Molecule Inhibitors of the ETS family of Transcription Factors (BIDMC 1017) |
| + Inhibiting Tumor Angiogenesis (BIDMC 368) |
| + Inhibitors of Phosphoserine and Phosphothreonine-Proline-Specific Isomerases as Cancer Therapeutics (BIDMC 278) |
| + Lipocalin 2 for the Prevention and Treatment of Metastatic Cancer (BIDMC 906) |
| + Method and Apparatus for Recording an Electroencephalogram During Transcranial Magnetic Stimulation (BIDMC 55)
|
| + Methods and Compounds for Prevention of Tissue Graft Rejection (BIDMC 244) |
| + Methods of Neuroendocrine Regulation to Treat Depression (BIDMC 169) |
| + Migraine Prophylaxis (BIDMC 1357) |
| + Novel Therapy for Vascular Inflammatory Diseases (BIDMC 1086) |
| + Protection from Acetaminophen Liver Toxicity (BIDMC 1289) |
| + Soluble Endoglin Components for Cancer Treatment (BIDMC1059) |
| + Stem Cell Therapy for Basement Membrane Diseases (BIDMC 905) |
| + Therapeutic Agents to Enhance Liver Repair & Regeneration (BIDMC 1259) |
| + Therapeutic to Regulate Glucose Homeostasis (BIDMC 1113) |
Category: Vaccines |
| + HIV-1 Vaccine Antigens with Improved Cellular Immune Breadth (BIDMC 1244) |
| + Recombinant Adenoviruses Based on Serotypes with Low Prevalence in Humans (BIDMC 973) |
| + Viral Vector Targeting (BIDMC 879) |
